July 2024 FDA Recall Nitrofurantion by Sun Pharmaceutical Industries Inc
D-0597-2024 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on July 9, 2024 for the product Nitrofurantion. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0597-2024

Reason for Recall
Failed Dissolution Specifications
Initiated
07-09-2024
Reported
07-24-2024
Quantity
5752 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
SUN PHARMACEUTICAL INDUSTRIES INC
Nationwide in the USA and Puerto rico
Nitrofurantoin Capsules, USP (Macrocrystals), 100 mg, Rx Only, 100 capsules per bottle, Manufactured by: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun - 248-197, Uttarakhand, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-233-88.

Batch or Lot Expiration Information

Lot# s: 231067, 231069, Exp 04/30/2025